Judge: Investors Failed To Show Involvement In Market Manipulation Scheme
(January 11, 2017, 2:57 PM EST) -- NEW YORK — Shareholders have failed to show that a biopharmaceutical company and certain of its executive officers and directors engaged in a market manipulation scheme because the shareholders failed to...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login